With US marketing campaign already peaked this Sodastream thing will have to sell itself. No more "in your face" advertising to lure consumers. Game Over!! Guidance #'s are too optimistic. IMO.
"I missed another fill order! "
So you're not willing to pay 48 and change for it? Sorry i forgot you knew it was going down. LOL
What's laughable is the novelty product he is peddling to consumers of which 50% will never use it again in a few months. 25% yearly revenue growth after just hitting the market? LOL
This poster buys more then usual for earnings and then tells everyone a selloff was a "no-brainer". Yeah, i'm the idiot. LOL
What is wrong with you? I said you held "more then usual for earnings" which you just confirmed here: "I USUALLY ride ER JUST below equalweight. This time, I held equalweight." You're a "no-brainer". LOL
Context? LOL You're just #$%$ because i called you out on your "no-brainer selloff" comment after saying you held more then usual. This board is hilarious.
The joke is on you Longs. Only a matter of time till a measly 25% revenue growth becomes Negative revenue growth. Management were overly optimistic with Guidance. IMO.
Fast Growing? They guided FY2013 sales to a increase of only 25%, which is the lowest since they went public. The US marketing campaign has peaked and it only hit 1%. This product does not sell itself.
Also you mention they have 50% of the world to expand to. Do you have any idea how hard it is to market a product like this in say China or Brazil? The US was a piece of cake in comparison.
You have no idea. You'll be kicking yourself when this is at $2.50 in a few months. Now Bye Bye.
The most promising data so far has been for the GVHD indication and we will hear back from the FDA regarding clearance for a Phase 2/3 pivotal trial soon. The Pfizer IBD indication is not be all and end all. Please do some research.
Sentiment: Strong Buy
That Dung poster is the quintessential "weak hand". He just read the proxy yesterday even though it was filed over a month ago. Smart traders are loading here. IMO.
Thanks but i wasn't really looking for a reply. I just want people to realize that there is so much more to Athersys then the Pfizer deal and your "pennies" remark was just you hating on the stock. :)
Damn it. This sucks cause i always get my advice from a Yahoo Message Board. LOL. Hey did they sign up any more retailers today? That's so important cause this deals are gold. LOL
Revenue Growth of 25% this year. And posters here wonder why it's going down. LOL
You mean you even plageurised some other persons
research. At least be original. :)
I have no clue who "Smith on Stocks" is and i don't really care,
unless he can tell me the results of the clincial trials. That
excerpt you posted mentions the word "trials". He is referring
to the Pfizer IBD trial AND the unpartnered Stroke trial.
Being the hater you are you just decided to leave out the
stroke trial when you remarked about it going to "pennies".
Stroke trial data is Q1 2014 so you'll have to stick around a
little longer before you see them. Even then we will have an
ongoing Phase 2/3 trial for GVHD (Orphan Drug Status) which
has already shown promising results. Get it yet hater? :)
US marketing campaign has peaked and they only were able reach 1% of Households. Big business has no interest in creating a competing product and that speaks volumes. The Longs on this board are nutty.